Successful rheumatic therapy with biosimilars

Corporate film for Association Pro Generika

Rheumatism is a disease that has many faces. There are more than a hundred different clinical pictures. Often it is difficult to identify them clearly, but it is so important that a diagnosis is made quickly. Only then rheumatologists can start a personalized treatment. Biological medicines, so-called biopharmaceutical, play an important role in the therapy. They can delay the course of the disease and, above all, relieve pain.

Filming with a patient and rheumatologist in Berlin

For the working group Pro Biosimilars our film production produced a corporate film about the this subject in August and September. How do biosimilars, the replicas of biopharmaceutical, influence rheumatic diseases? We met a patient in Berlin who has been ill for more than twenty years. She told us impressively how the biosimilars changed her life. We also talked to her rheumatologist who has been prescribing biopharmaceutical and biosimilars for many years.

Supply Bottlenecks for essential antibiotics

Corporate film for the association Pro Generika, Berlin

Again and again, even in the case of essential medicines such as antibiotics, there are bottlenecks. What impact do they have on supply? Would it be possible to produce more antibiotics in Germany in future times in order to make supplies more secure? The film, which we produced for the association "Pro Generika e. V." tries to find answers.